nodes	percent_of_prediction	percent_of_DWPC	metapath
Toremifene—ABCB1—Parkinson's disease	0.865	1	CbGaD
Toremifene—Benzphetamine—SLC18A2—Parkinson's disease	0.00243	0.266	CrCbGaD
Toremifene—Clomifene—CYP2E1—Parkinson's disease	0.00122	0.133	CrCbGaD
Toremifene—Benzphetamine—SLC6A3—Parkinson's disease	0.00101	0.11	CrCbGaD
Toremifene—Clomifene—ABCB1—Parkinson's disease	0.000639	0.07	CrCbGaD
Toremifene—Dextropropoxyphene—CYP2D6—Parkinson's disease	0.000604	0.0662	CrCbGaD
Toremifene—Loperamide—CYP2D6—Parkinson's disease	0.000576	0.0631	CrCbGaD
Toremifene—Tamoxifen—CYP2E1—Parkinson's disease	0.000563	0.0617	CrCbGaD
Toremifene—Orphenadrine—CYP2E1—Parkinson's disease	0.000547	0.0599	CrCbGaD
Toremifene—Diphenhydramine—CYP2D6—Parkinson's disease	0.000425	0.0465	CrCbGaD
Toremifene—Tamoxifen—CYP2D6—Parkinson's disease	0.000413	0.0453	CrCbGaD
Toremifene—Loperamide—ABCB1—Parkinson's disease	0.000411	0.045	CrCbGaD
Toremifene—Tamoxifen—ABCB1—Parkinson's disease	0.000295	0.0323	CrCbGaD
Toremifene—ESR1—Integrated Pancreatic Cancer Pathway—ABL1—Parkinson's disease	0.00027	0.00214	CbGpPWpGaD
Toremifene—ESR1—Integrated Pancreatic Cancer Pathway—BDNF—Parkinson's disease	0.000266	0.00211	CbGpPWpGaD
Toremifene—CYP1A1—Biological oxidations—CYP2D6—Parkinson's disease	0.000264	0.00209	CbGpPWpGaD
Toremifene—ESR1—Integrated Pancreatic Cancer Pathway—ABCB1—Parkinson's disease	0.000261	0.00207	CbGpPWpGaD
Toremifene—CYP1A1—Metapathway biotransformation—CYP2D6—Parkinson's disease	0.00026	0.00206	CbGpPWpGaD
Toremifene—ESR1—Leptin signaling pathway—MAPK8—Parkinson's disease	0.000258	0.00204	CbGpPWpGaD
Toremifene—CYP1A2—Biological oxidations—GSTA4—Parkinson's disease	0.000254	0.00201	CbGpPWpGaD
Toremifene—ABCB1—Allograft Rejection—FASLG—Parkinson's disease	0.000253	0.00201	CbGpPWpGaD
Toremifene—CYP1A2—Metapathway biotransformation—GSTA4—Parkinson's disease	0.00025	0.00199	CbGpPWpGaD
Toremifene—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—CTGF—Parkinson's disease	0.00025	0.00198	CbGpPWpGaD
Toremifene—CYP3A4—Phase 1 - Functionalization of compounds—CYP2D6—Parkinson's disease	0.000244	0.00194	CbGpPWpGaD
Toremifene—CYP1A1—Biological oxidations—CYP2E1—Parkinson's disease	0.000241	0.00191	CbGpPWpGaD
Toremifene—CYP1A2—Phase 1 - Functionalization of compounds—MAOA—Parkinson's disease	0.000238	0.00189	CbGpPWpGaD
Toremifene—CYP1A1—Metapathway biotransformation—CYP2E1—Parkinson's disease	0.000238	0.00189	CbGpPWpGaD
Toremifene—ABCB1—Integrated Pancreatic Cancer Pathway—MAPT—Parkinson's disease	0.000236	0.00188	CbGpPWpGaD
Toremifene—ESR1—Integrated Pancreatic Cancer Pathway—FASLG—Parkinson's disease	0.000236	0.00187	CbGpPWpGaD
Toremifene—CYP1A2—Biological oxidations—MAOB—Parkinson's disease	0.000226	0.00179	CbGpPWpGaD
Toremifene—CYP3A4—Phase 1 - Functionalization of compounds—CYP2E1—Parkinson's disease	0.000223	0.00177	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism of lipids and lipoproteins—GBA—Parkinson's disease	0.000221	0.00175	CbGpPWpGaD
Toremifene—CYP1A2—Phase II conjugation—COMT—Parkinson's disease	0.000218	0.00173	CbGpPWpGaD
Toremifene—CYP1A2—Phase II conjugation—GSTP1—Parkinson's disease	0.000217	0.00172	CbGpPWpGaD
Toremifene—CYP1A1—Biological oxidations—COMT—Parkinson's disease	0.0002	0.00158	CbGpPWpGaD
Toremifene—CYP1A1—Aryl Hydrocarbon Receptor Pathway—TNF—Parkinson's disease	0.0002	0.00158	CbGpPWpGaD
Toremifene—CYP1A1—Aryl Hydrocarbon Receptor—TNF—Parkinson's disease	0.0002	0.00158	CbGpPWpGaD
Toremifene—ESR1—ATF-2 transcription factor network—IL6—Parkinson's disease	0.000199	0.00158	CbGpPWpGaD
Toremifene—CYP1A2—Phase II conjugation—GSTM1—Parkinson's disease	0.000199	0.00158	CbGpPWpGaD
Toremifene—CYP1A1—Biological oxidations—GSTP1—Parkinson's disease	0.000199	0.00158	CbGpPWpGaD
Toremifene—CYP1A1—Biological oxidations—MAOA—Parkinson's disease	0.000198	0.00157	CbGpPWpGaD
Toremifene—CYP1A1—Metapathway biotransformation—COMT—Parkinson's disease	0.000197	0.00156	CbGpPWpGaD
Toremifene—ABCB1—Transmembrane transport of small molecules—ATP1A3—Parkinson's disease	0.000197	0.00156	CbGpPWpGaD
Toremifene—ABCB1—Transmembrane transport of small molecules—TRPM7—Parkinson's disease	0.000197	0.00156	CbGpPWpGaD
Toremifene—CYP1A1—Metapathway biotransformation—GSTP1—Parkinson's disease	0.000196	0.00156	CbGpPWpGaD
Toremifene—CYP3A4—Biological oxidations—GSTA4—Parkinson's disease	0.000196	0.00155	CbGpPWpGaD
Toremifene—CYP3A4—Metapathway biotransformation—GSTA4—Parkinson's disease	0.000193	0.00153	CbGpPWpGaD
Toremifene—ESR1—Gene Expression—TAF1—Parkinson's disease	0.000191	0.00151	CbGpPWpGaD
Toremifene—ESR1—Gene Expression—NR4A2—Parkinson's disease	0.000191	0.00151	CbGpPWpGaD
Toremifene—CYP3A4—Phase 1 - Functionalization of compounds—MAOA—Parkinson's disease	0.000184	0.00146	CbGpPWpGaD
Toremifene—CYP1A1—Biological oxidations—GSTM1—Parkinson's disease	0.000183	0.00145	CbGpPWpGaD
Toremifene—CYP1A1—Metapathway biotransformation—GSTM1—Parkinson's disease	0.00018	0.00143	CbGpPWpGaD
Toremifene—ESR1—Generic Transcription Pathway—CTGF—Parkinson's disease	0.000179	0.00142	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—VPS35—Parkinson's disease	0.000176	0.0014	CbGpPWpGaD
Toremifene—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL1B—Parkinson's disease	0.000176	0.00139	CbGpPWpGaD
Toremifene—CYP3A4—Biological oxidations—MAOB—Parkinson's disease	0.000175	0.00138	CbGpPWpGaD
Toremifene—ESR1—AP-1 transcription factor network—IL6—Parkinson's disease	0.000174	0.00138	CbGpPWpGaD
Toremifene—CYP1A2—Biological oxidations—CYP2D6—Parkinson's disease	0.000168	0.00133	CbGpPWpGaD
Toremifene—CYP1A2—Metapathway biotransformation—CYP2D6—Parkinson's disease	0.000166	0.00132	CbGpPWpGaD
Toremifene—ESR1—Integrated Breast Cancer Pathway—CASP3—Parkinson's disease	0.00016	0.00127	CbGpPWpGaD
Toremifene—CYP1A2—Biological oxidations—CYP2E1—Parkinson's disease	0.000154	0.00122	CbGpPWpGaD
Toremifene—ESR1—Gene Expression—RPL6—Parkinson's disease	0.000152	0.00121	CbGpPWpGaD
Toremifene—CYP1A2—Metapathway biotransformation—CYP2E1—Parkinson's disease	0.000152	0.0012	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—DGKQ—Parkinson's disease	0.000146	0.00116	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—GPR37—Parkinson's disease	0.000146	0.00116	CbGpPWpGaD
Toremifene—ABCB1—Integrated Pancreatic Cancer Pathway—ABL1—Parkinson's disease	0.000143	0.00113	CbGpPWpGaD
Toremifene—ABCB1—Allograft Rejection—IL1B—Parkinson's disease	0.000143	0.00113	CbGpPWpGaD
Toremifene—ABCB1—Allograft Rejection—CASP3—Parkinson's disease	0.000142	0.00113	CbGpPWpGaD
Toremifene—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—Parkinson's disease	0.000141	0.00112	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism of lipids and lipoproteins—GBA—Parkinson's disease	0.000141	0.00112	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism of lipids and lipoproteins—PLA2G6—Parkinson's disease	0.000138	0.00109	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—PPP1R1B—Parkinson's disease	0.000133	0.00106	CbGpPWpGaD
Toremifene—ESR1—Integrated Pancreatic Cancer Pathway—CASP3—Parkinson's disease	0.000133	0.00105	CbGpPWpGaD
Toremifene—CYP3A4—Biological oxidations—CYP2D6—Parkinson's disease	0.00013	0.00103	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—ND3—Parkinson's disease	0.00013	0.00103	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—MCCC1—Parkinson's disease	0.00013	0.00103	CbGpPWpGaD
Toremifene—CYP3A4—Metapathway biotransformation—CYP2D6—Parkinson's disease	0.000128	0.00102	CbGpPWpGaD
Toremifene—CYP1A2—Biological oxidations—COMT—Parkinson's disease	0.000127	0.00101	CbGpPWpGaD
Toremifene—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—Parkinson's disease	0.000127	0.00101	CbGpPWpGaD
Toremifene—CYP1A2—Aryl Hydrocarbon Receptor—TNF—Parkinson's disease	0.000127	0.00101	CbGpPWpGaD
Toremifene—CYP1A2—Biological oxidations—GSTP1—Parkinson's disease	0.000127	0.00101	CbGpPWpGaD
Toremifene—CYP1A2—Biological oxidations—MAOA—Parkinson's disease	0.000127	0.001	CbGpPWpGaD
Toremifene—CYP1A2—Metapathway biotransformation—COMT—Parkinson's disease	0.000126	0.000997	CbGpPWpGaD
Toremifene—CYP1A2—Metapathway biotransformation—GSTP1—Parkinson's disease	0.000125	0.000992	CbGpPWpGaD
Toremifene—ABCB1—Integrated Pancreatic Cancer Pathway—FASLG—Parkinson's disease	0.000125	0.00099	CbGpPWpGaD
Toremifene—ESR1—Integrated Pancreatic Cancer Pathway—MAPK8—Parkinson's disease	0.000122	0.000968	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—TALDO1—Parkinson's disease	0.000122	0.000966	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—OMD—Parkinson's disease	0.000122	0.000966	CbGpPWpGaD
Toremifene—CYP3A4—Biological oxidations—CYP2E1—Parkinson's disease	0.000119	0.000941	CbGpPWpGaD
Toremifene—CYP3A4—Metapathway biotransformation—CYP2E1—Parkinson's disease	0.000117	0.000928	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—RIT2—Parkinson's disease	0.000117	0.000924	CbGpPWpGaD
Toremifene—CYP1A2—Biological oxidations—GSTM1—Parkinson's disease	0.000117	0.000924	CbGpPWpGaD
Toremifene—ESR1—Gene Expression—RPL23A—Parkinson's disease	0.000116	0.000916	CbGpPWpGaD
Toremifene—ESR1—Gene Expression—RPL14—Parkinson's disease	0.000116	0.000916	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—NDUFB11—Parkinson's disease	0.000116	0.000916	CbGpPWpGaD
Toremifene—CYP1A2—Metapathway biotransformation—GSTM1—Parkinson's disease	0.000115	0.000912	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—GRK5—Parkinson's disease	0.000111	0.000876	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—GCH1—Parkinson's disease	0.00011	0.000874	CbGpPWpGaD
Toremifene—ESR1—Gene Expression—RPS8—Parkinson's disease	0.000108	0.000854	CbGpPWpGaD
Toremifene—ABCB1—Transmembrane transport of small molecules—SLC18A2—Parkinson's disease	0.000105	0.000829	CbGpPWpGaD
Toremifene—ABCB1—Allograft Rejection—TNF—Parkinson's disease	0.000104	0.000821	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—MCCC1—Parkinson's disease	0.000104	0.000821	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—ND3—Parkinson's disease	0.000104	0.000821	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism of lipids and lipoproteins—CTGF—Parkinson's disease	9.94e-05	0.000788	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—GRM4—Parkinson's disease	9.91e-05	0.000786	CbGpPWpGaD
Toremifene—CYP3A4—Biological oxidations—COMT—Parkinson's disease	9.84e-05	0.00078	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—DBH—Parkinson's disease	9.82e-05	0.000779	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—FBP1—Parkinson's disease	9.82e-05	0.000779	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—GBA—Parkinson's disease	9.82e-05	0.000779	CbGpPWpGaD
Toremifene—CYP3A4—Biological oxidations—GSTP1—Parkinson's disease	9.79e-05	0.000776	CbGpPWpGaD
Toremifene—CYP3A4—Biological oxidations—MAOA—Parkinson's disease	9.77e-05	0.000774	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—TALDO1—Parkinson's disease	9.73e-05	0.000772	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—OMD—Parkinson's disease	9.73e-05	0.000772	CbGpPWpGaD
Toremifene—CYP3A4—Metapathway biotransformation—COMT—Parkinson's disease	9.7e-05	0.000769	CbGpPWpGaD
Toremifene—ESR1—Integrated Pancreatic Cancer Pathway—TNF—Parkinson's disease	9.66e-05	0.000766	CbGpPWpGaD
Toremifene—CYP3A4—Metapathway biotransformation—GSTP1—Parkinson's disease	9.65e-05	0.000766	CbGpPWpGaD
Toremifene—ABCB1—Transmembrane transport of small molecules—CP—Parkinson's disease	9.62e-05	0.000763	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—PENK—Parkinson's disease	9.4e-05	0.000745	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—MAG—Parkinson's disease	9.4e-05	0.000745	CbGpPWpGaD
Toremifene—ESR1—Signaling by ERBB4—IL6—Parkinson's disease	9.36e-05	0.000742	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—NDUFB11—Parkinson's disease	9.23e-05	0.000732	CbGpPWpGaD
Toremifene—CYP3A4—Biological oxidations—GSTM1—Parkinson's disease	9e-05	0.000713	CbGpPWpGaD
Toremifene—CYP3A4—Metapathway biotransformation—GSTM1—Parkinson's disease	8.87e-05	0.000704	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—GCH1—Parkinson's disease	8.8e-05	0.000698	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism of lipids and lipoproteins—PLA2G6—Parkinson's disease	8.78e-05	0.000696	CbGpPWpGaD
Toremifene—ESR1—Gene Expression—HSPA8—Parkinson's disease	8.63e-05	0.000685	CbGpPWpGaD
Toremifene—ESR1—Gene Expression—CTGF—Parkinson's disease	8.59e-05	0.000682	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—PDYN—Parkinson's disease	8.59e-05	0.000682	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—ND3—Parkinson's disease	8.26e-05	0.000655	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—MCCC1—Parkinson's disease	8.26e-05	0.000655	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—GFAP—Parkinson's disease	8.08e-05	0.000641	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—GRM5—Parkinson's disease	7.99e-05	0.000634	CbGpPWpGaD
Toremifene—ESR1—Gene Expression—HSPA1A—Parkinson's disease	7.86e-05	0.000623	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—GBA—Parkinson's disease	7.85e-05	0.000622	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—DBH—Parkinson's disease	7.85e-05	0.000622	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—FBP1—Parkinson's disease	7.85e-05	0.000622	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—OMD—Parkinson's disease	7.77e-05	0.000616	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—TALDO1—Parkinson's disease	7.77e-05	0.000616	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—NDUFB11—Parkinson's disease	7.37e-05	0.000584	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—DDC—Parkinson's disease	7.21e-05	0.000572	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—GCH1—Parkinson's disease	7.03e-05	0.000557	CbGpPWpGaD
Toremifene—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—Parkinson's disease	7.03e-05	0.000557	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—FGF20—Parkinson's disease	7.01e-05	0.000556	CbGpPWpGaD
Toremifene—ABCB1—Transmembrane transport of small molecules—SLC6A3—Parkinson's disease	6.86e-05	0.000544	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—GSTA4—Parkinson's disease	6.81e-05	0.00054	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—ADORA2A—Parkinson's disease	6.79e-05	0.000539	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism of lipids and lipoproteins—GPX1—Parkinson's disease	6.72e-05	0.000533	CbGpPWpGaD
Toremifene—ABCB1—Transmembrane transport of small molecules—CYCS—Parkinson's disease	6.58e-05	0.000522	CbGpPWpGaD
Toremifene—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK8—Parkinson's disease	6.46e-05	0.000512	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—ND3—Parkinson's disease	6.38e-05	0.000506	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—MCCC1—Parkinson's disease	6.38e-05	0.000506	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism of lipids and lipoproteins—CTGF—Parkinson's disease	6.34e-05	0.000503	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—INSR—Parkinson's disease	6.27e-05	0.000497	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—FBP1—Parkinson's disease	6.26e-05	0.000497	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—DBH—Parkinson's disease	6.26e-05	0.000497	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—GBA—Parkinson's disease	6.26e-05	0.000497	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—PLA2G6—Parkinson's disease	6.13e-05	0.000486	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—MAOB—Parkinson's disease	6.07e-05	0.000481	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—TALDO1—Parkinson's disease	6e-05	0.000476	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—OMD—Parkinson's disease	6e-05	0.000476	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—FGB—Parkinson's disease	5.93e-05	0.00047	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—HTR1A—Parkinson's disease	5.89e-05	0.000467	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—TAC1—Parkinson's disease	5.81e-05	0.00046	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism of lipids and lipoproteins—APOE—Parkinson's disease	5.78e-05	0.000458	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—DDC—Parkinson's disease	5.76e-05	0.000457	CbGpPWpGaD
Toremifene—ABCB1—Transmembrane transport of small molecules—HMOX1—Parkinson's disease	5.72e-05	0.000454	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—DRD1—Parkinson's disease	5.69e-05	0.000451	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—NDUFB11—Parkinson's disease	5.68e-05	0.000451	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—DRD3—Parkinson's disease	5.51e-05	0.000437	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—GSTA4—Parkinson's disease	5.44e-05	0.000431	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—GCH1—Parkinson's disease	5.42e-05	0.00043	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—ADRBK1—Parkinson's disease	5.15e-05	0.000408	CbGpPWpGaD
Toremifene—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—Parkinson's disease	5.11e-05	0.000405	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—HTR7—Parkinson's disease	4.99e-05	0.000395	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—DRD2—Parkinson's disease	4.99e-05	0.000395	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—PLA2G6—Parkinson's disease	4.9e-05	0.000388	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—MAOB—Parkinson's disease	4.85e-05	0.000384	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—GBA—Parkinson's disease	4.83e-05	0.000383	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—DBH—Parkinson's disease	4.83e-05	0.000383	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—FBP1—Parkinson's disease	4.83e-05	0.000383	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—DDC—Parkinson's disease	4.6e-05	0.000365	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—CYP2D6—Parkinson's disease	4.51e-05	0.000358	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—CTGF—Parkinson's disease	4.43e-05	0.000351	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—GSTA4—Parkinson's disease	4.34e-05	0.000344	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—Parkinson's disease	4.29e-05	0.00034	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—IGF2—Parkinson's disease	4.18e-05	0.000331	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—CYP2E1—Parkinson's disease	4.12e-05	0.000327	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—NQO1—Parkinson's disease	4.08e-05	0.000323	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—IGF1R—Parkinson's disease	4.04e-05	0.00032	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—TH—Parkinson's disease	4.02e-05	0.000319	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—EDN1—Parkinson's disease	3.99e-05	0.000317	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—PLA2G6—Parkinson's disease	3.91e-05	0.00031	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—MAOB—Parkinson's disease	3.87e-05	0.000307	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—CYCS—Parkinson's disease	3.86e-05	0.000306	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism of lipids and lipoproteins—APOE—Parkinson's disease	3.68e-05	0.000292	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—NGF—Parkinson's disease	3.67e-05	0.000291	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—CYP2D6—Parkinson's disease	3.6e-05	0.000286	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—DDC—Parkinson's disease	3.55e-05	0.000281	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—CTGF—Parkinson's disease	3.54e-05	0.00028	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—HTR2A—Parkinson's disease	3.49e-05	0.000277	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—COMT—Parkinson's disease	3.42e-05	0.000271	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—GSTP1—Parkinson's disease	3.4e-05	0.00027	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—MAOA—Parkinson's disease	3.39e-05	0.000269	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—HMOX1—Parkinson's disease	3.36e-05	0.000266	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—GSTA4—Parkinson's disease	3.35e-05	0.000266	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—CYP2E1—Parkinson's disease	3.29e-05	0.000261	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—NQO1—Parkinson's disease	3.26e-05	0.000258	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—APOE—Parkinson's disease	3.25e-05	0.000257	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—ABCB1—Parkinson's disease	3.22e-05	0.000255	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—TH—Parkinson's disease	3.21e-05	0.000255	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—GSTM1—Parkinson's disease	3.13e-05	0.000248	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—CYCS—Parkinson's disease	3.08e-05	0.000244	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—PLA2G6—Parkinson's disease	3.02e-05	0.000239	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—GPX1—Parkinson's disease	2.99e-05	0.000237	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—MAOB—Parkinson's disease	2.99e-05	0.000237	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—CYP2D6—Parkinson's disease	2.88e-05	0.000228	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—CTGF—Parkinson's disease	2.82e-05	0.000224	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—INS—Parkinson's disease	2.77e-05	0.00022	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—MTHFR—Parkinson's disease	2.76e-05	0.000219	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—COMT—Parkinson's disease	2.73e-05	0.000216	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—GSTP1—Parkinson's disease	2.72e-05	0.000215	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—MAOA—Parkinson's disease	2.71e-05	0.000215	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—HMOX1—Parkinson's disease	2.68e-05	0.000213	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—CYP2E1—Parkinson's disease	2.63e-05	0.000209	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—NQO1—Parkinson's disease	2.6e-05	0.000206	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—APOE—Parkinson's disease	2.57e-05	0.000204	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—TH—Parkinson's disease	2.56e-05	0.000203	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—GSTM1—Parkinson's disease	2.5e-05	0.000198	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—CYCS—Parkinson's disease	2.46e-05	0.000195	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—GPX1—Parkinson's disease	2.39e-05	0.00019	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—CYP2D6—Parkinson's disease	2.22e-05	0.000176	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—MTHFR—Parkinson's disease	2.21e-05	0.000175	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—INS—Parkinson's disease	2.2e-05	0.000174	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—COMT—Parkinson's disease	2.18e-05	0.000173	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—CTGF—Parkinson's disease	2.18e-05	0.000173	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—GSTP1—Parkinson's disease	2.17e-05	0.000172	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—MAOA—Parkinson's disease	2.16e-05	0.000172	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—HMOX1—Parkinson's disease	2.14e-05	0.00017	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—CASP3—Parkinson's disease	2.07e-05	0.000164	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—APOE—Parkinson's disease	2.05e-05	0.000163	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—ABCB1—Parkinson's disease	2.05e-05	0.000163	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—CYP2E1—Parkinson's disease	2.03e-05	0.000161	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—NQO1—Parkinson's disease	2.01e-05	0.000159	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—GSTM1—Parkinson's disease	1.99e-05	0.000158	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—TH—Parkinson's disease	1.98e-05	0.000157	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—GPX1—Parkinson's disease	1.91e-05	0.000151	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—CYCS—Parkinson's disease	1.9e-05	0.000151	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—MAPK8—Parkinson's disease	1.9e-05	0.000151	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—MTHFR—Parkinson's disease	1.76e-05	0.00014	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—INS—Parkinson's disease	1.76e-05	0.000139	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—COMT—Parkinson's disease	1.68e-05	0.000133	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—GSTP1—Parkinson's disease	1.67e-05	0.000133	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—MAOA—Parkinson's disease	1.67e-05	0.000132	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—HMOX1—Parkinson's disease	1.65e-05	0.000131	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—APOE—Parkinson's disease	1.64e-05	0.00013	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—ABCB1—Parkinson's disease	1.58e-05	0.000126	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—GSTM1—Parkinson's disease	1.54e-05	0.000122	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—GPX1—Parkinson's disease	1.47e-05	0.000117	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—INS—Parkinson's disease	1.4e-05	0.000111	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—MTHFR—Parkinson's disease	1.36e-05	0.000108	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—APOE—Parkinson's disease	1.27e-05	0.0001	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—IL6—Parkinson's disease	1.21e-05	9.61e-05	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—INS—Parkinson's disease	1.08e-05	8.57e-05	CbGpPWpGaD
